Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Status:
Withdrawn
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of paclitaxel in combination
with cyclophosphamide and dexamethasone in chinese patients with relapsed/refractory multiple
myeloma.